RecruitingNot ApplicableNCT05996159

Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation

Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation: Q-INDEX Trial


Sponsor

Seoul National University Hospital

Enrollment

150 participants

Start Date

Nov 7, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to investigate the effect of reducing ablation time for a hybrid approach of vHPSD and AI-guided ablation using the QDOT Micro catheter in PVI among patients with PAF.


Eligibility

Min Age: 19 Years

Inclusion Criteria1

  • Patients undergoing PVI for PAF

Exclusion Criteria10

  • Aged less than 19 years
  • Patients with persistent AF
  • Patients with previous ablation or surgery for AF
  • Patients with intracardiac thrombus or thromboembolic events within the previous 90 days
  • Patients with cardiac surgery or acute coronary syndrome within the previous 90 days
  • Patients with contraindication(s) for using oral anticoagulants
  • Patients with LA anteroposterior diameter of more than 55 mm
  • Patients with left ventricular ejection fraction less than 35%
  • Pregnants or those who plan to become pregnant during the study
  • Life expectancy less than a year

Interventions

DEVICEQDOT MicroTM catheter

Novel high power-short duration ablation catheter for atrial fibrillation

DEVICEAI-guided ablation only for PVI

Ablation is the removal or destruction of something from an object by vaporization, chipping, erosive processes, or by other means.


Locations(1)

Seoul National University Hospital

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05996159


Related Trials